BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 19766730)

  • 1. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
    Majhail NS; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
    Majhail NS; DeFor T; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
    Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
    Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation.
    Jacobi N; Herich L
    Eur J Haematol; 2016 Oct; 97(4):336-41. PubMed ID: 26800433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
    Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
    Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation.
    Kanda J; Mizumoto C; Kawabata H; Ichinohe T; Tsuchida H; Tomosugi N; Matsuo K; Yamashita K; Kondo T; Ishikawa T; Uchiyama T
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):956-62. PubMed ID: 19589485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
    Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Karakan T; Akyol G
    Bone Marrow Transplant; 2008 Oct; 42(7):461-7. PubMed ID: 18604240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
    Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
    Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload in hematopoietic cell transplantation.
    Majhail NS; Lazarus HM; Burns LJ
    Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity.
    de la Serna J; Bornstein R; García-Bueno MJ; Lahuerta-Palacios JJ
    Bone Marrow Transplant; 1999 Jan; 23(1):95-7. PubMed ID: 10037058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation.
    Brissot E; Savani BN; Mohty M
    Semin Hematol; 2012 Jan; 49(1):35-42. PubMed ID: 22221783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
    Hicken BL; Tucker DC; Barton JC
    Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation.
    Yegin ZA; Paşaoğlu H; Aki SZ; Özkurt ZN; Demirtaş C; Yağci M; Acar K; Sucak GT
    Int J Lab Hematol; 2011 Aug; 33(4):414-23. PubMed ID: 21310008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.